Irf9 signalling in vagal sensory ganglia shapes neuroimmune responses and disease severity during influenza A virus infection

Abstract Influenza A virus (IAV) remains a major cause of global morbidity and mortality. Although the role of pulmonary immune cells has been extensively studied, there is increasing evidence that airway-innervating vagal sensory neurons play an important role during respiratory viral infection. These neurons have been shown to influence pulmonary inflammation, and disease outcomes. We previously showed that vagal sensory neurons undergo transcriptional changes following IAV infection, including upregulation of interferon regulatory factor 9 ( Irf9 ). IRF9 is a key mediator in type I and III interferon signalling, yet its role in vagal sensory neurons remains undefined. Here, we investigate the effects of targeted Irf9 knockdown within vagal sensory ganglia on the clinical and pathological presentation of IAV disease. Using bilateral intraganglionic microinjections of AAV-delivered short hairpin RNA, we selectively knocked down Irf9 within the vagal sensory ganglia. Transduction efficiency was confirmed by the reporter protein GFP, and Irf9 gene expression was significantly reduced in IAV-infected knockdown animals compared with IAV-infected scramble controls. Knockdown of vagal Irf9 was associated with exacerbated clinical disease severity, reflected by greater weight loss, higher clinical severity scores, and altered respiratory parameters during infection. Despite these clinical effects, Irf9 knockdown did not alter pulmonary viral load or cytokine responses in lung or serum, indicating that worsened disease was not driven by peripheral anti-viral immune responses. However, Irf9 knockdown was accompanied by increased number of inflammatory cells within the vagal sensory ganglia and changes in the local ganglia proteomic profile. These findings raise the possibility that Irf9 may contribute to regulating neuronal signalling pathways and help shape physiological determinants of disease severity.

Authors

Institutions

Publication Details

Journal
Journal of Neuroinflammation
Published
2026-11-12
DOI
https://doi.org/10.1186/s12974-026-04116-3
Primary Topic
Vagus Nerve Stimulation Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Irf9 signalling in vagal sensory ganglia shapes neuroimmune responses and disease severity during influenza A virus infection

Stuart B. Mazzone, Kirsty Renfree Short, Matthew W. Trewella, Alice E. McGovern et al.
Journal of Neuroinflammation
Vagus Nerve Stimulation Research
article

Irf9 signalling in vagal sensory ganglia shapes neuroimmune responses and disease severity during influenza A virus infection

Stuart B. Mazzone, Kirsty Renfree Short, Matthew W. Trewella, Alice E. McGovern, Nathalie A. J. Verzele, Kalyan Shobhana, Helle Bielefeldt-Ohmann, Swati Varshney
article en

Abstract

Abstract Influenza A virus (IAV) remains a major cause of global morbidity and mortality. Although the role of pulmonary immune cells has been extensively studied, there is increasing evidence that airway-innervating vagal sensory neurons play an important role during respiratory viral infection. These neurons have been shown to influence pulmonary inflammation, and disease outcomes. We previously showed that vagal sensory neurons undergo transcriptional changes following IAV infection, including upregulation of interferon regulatory factor 9 ( Irf9 ). IRF9 is a key mediator in type I and III interferon signalling, yet its role in vagal sensory neurons remains undefined. Here, we investigate the effects of targeted Irf9 knockdown within vagal sensory ganglia on the clinical and pathological presentation of IAV disease. Using bilateral intraganglionic microinjections of AAV-delivered short hairpin RNA, we selectively knocked down Irf9 within the vagal sensory ganglia. Transduction efficiency was confirmed by the reporter protein GFP, and Irf9 gene expression was significantly reduced in IAV-infected knockdown animals compared with IAV-infected scramble controls. Knockdown of vagal Irf9 was associated with exacerbated clinical disease severity, reflected by greater weight loss, higher clinical severity scores, and altered respiratory parameters during infection. Despite these clinical effects, Irf9 knockdown did not alter pulmonary viral load or cytokine responses in lung or serum, indicating that worsened disease was not driven by peripheral anti-viral immune responses. However, Irf9 knockdown was accompanied by increased number of inflammatory cells within the vagal sensory ganglia and changes in the local ganglia proteomic profile. These findings raise the possibility that Irf9 may contribute to regulating neuronal signalling pathways and help shape physiological determinants of disease severity.

Journal of Neuroinflammation
The University of Queensland (AU), The University of Melbourne (AU)
Australian Research Council, National Health and Medical Research Council
Good health and well-being
Vagus Nerve Stimulation Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon